Provided by Tiger Trade Technology Pte. Ltd.

Novo-Nordisk A/S

62.89
-1.0900-1.70%
Post-market: 62.85-0.0400-0.06%19:59 EST
Volume:13.43M
Turnover:844.97M
Market Cap:279.17B
PE:17.16
High:63.49
Open:62.89
Low:62.49
Close:63.98
52wk High:93.80
52wk Low:43.08
Shares:4.44B
Float Shares:3.19B
Volume Ratio:0.52
T/O Rate:0.42%
Dividend:1.69
Dividend Rate:2.68%
EPS(TTM):3.67
EPS(LYR):3.15
ROE:71.46%
ROA:21.11%
PB:11.16
PE(LYR):19.98

Loading ...

Novo Nordisk Valuation Looks Appropriate Given Uncertainties -- Market Talk

Dow Jones
·
Yesterday

Novo Nordisk A/S Stock Falls Monday, Underperforms Market

Dow Jones
·
Yesterday

European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading

MT Newswires Live
·
Yesterday

Kepler Capital Sticks to Their Buy Rating for Novo Nordisk (0QIU)

TIPRANKS
·
Jan 25

Novo Nordisk (NYSE:NVO) Valuation Check After Mixed Returns And Undervalued Narrative

Simply Wall St.
·
Jan 24

Moderately bullish activity in Novo Nordisk with shares up 0.14%

TIPRANKS
·
Jan 24

Novo Nordisk’s Real‑World Semaglutide Study Hits Completion: What Investors Should Watch

TIPRANKS
·
Jan 24

Novo Nordisk Stock (NVO) Gains on Obesity Pill Demand as Goldman Flags Earnings Upside

TIPRANKS
·
Jan 23

Novo Nordisk’s Wegovy Pill Records Nearly 20,000 Prescriptions in First Week

TIPRANKS
·
Jan 23

Novo's 500% Pill Pop: Wegovy Just Obliterated Every GLP-1 Launch Record

Benzinga_recent_news
·
Jan 23

Novo Nordisk's Wegovy Pill Hits 18,410 US Prescriptions in First Week, Reuters Reports

MT Newswires Live
·
Jan 23

Sector Update: Health Care

MT Newswires Live
·
Jan 23

Novo's Wegovy pill tracks 18,410 prescriptions for first full week since launch

Reuters
·
Jan 23

Novo Nordisk (0QIU) Receives a Buy from Berenberg Bank

TIPRANKS
·
Jan 23

Novo Nordisk Jumps Another 3% as Wegovy Weight-Loss Drug Pill Prescriptions Surge

Dow Jones
·
Jan 23

Eli Lilly, Novo Nordisk Set for Fierce Battle in India’s Obesity Drug Market as Sun Pharma Wins Wegovy Generic Nod

TIPRANKS
·
Jan 23

Novo Nordisk A/S Stock Rises Thursday, Outperforms Market

Dow Jones
·
Jan 23

Novo Nordisk Advances CagriSema Device Study, Reinforcing Its Obesity Pipeline

TIPRANKS
·
Jan 23

Novo Nordisk’s CagriSema Trial Completes: What the Next-Gen Diabetes Combo Could Mean for NVO Investors

TIPRANKS
·
Jan 23

European Equities Traded in the US as American Depositary Receipts Track Higher in Thursday Trading

MT Newswires Live
·
Jan 23